Concepedia

Publication | Closed Access

Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial.

189

Citations

0

References

1997

Year

Ran Oren, Menachem Moshkowitz, Shmuel Odes, S Becker, Daniel Keter, I Pomeranz, Haim Shirin, C Shirin, I Reisfeld, E Broide,
PubMed

Abstract

Methotrexate at a weekly oral dose of 12.5 mg was found to be moderately better than 6-mercaptopurine and placebo in patients with chronic active CD.